Literature DB >> 31811013

Conscientious objection and moral distress: a relational ethics case study of MAiD in Canada.

Mary Kathleen Deutscher Heilman1, Tracy J Trothen2.   

Abstract

Conscientious objection has become a divisive topic in recent bioethics publications. Discussion has tended to frame the issue in terms of the rights of the healthcare professional versus the rights of the patient. However, a rights-based approach neglects the relational nature of conscience, and the impact that violating one's conscience has on the care one provides. Using medical assistance in dying as a case study, we suggest that what has been lacking in the discussion of conscientious objection thus far is a recognition and prioritising of the relational nature of ethical decision-making in healthcare and the negative consequences of moral distress that occur when healthcare professionals find themselves in situations in which they feel they cannot provide what they consider to be excellent care. We propose that policies that respect the relational conscience could benefit our healthcare institutions by minimising the negative impact of moral distress, improving communication among team members and fostering a culture of ethical awareness. Constructive responses to moral distress including relational cultivation of moral resilience are urged. © Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  conscientious objection; euthanasia; moral psychology

Mesh:

Year:  2019        PMID: 31811013     DOI: 10.1136/medethics-2019-105855

Source DB:  PubMed          Journal:  J Med Ethics        ISSN: 0306-6800            Impact factor:   2.903


  2 in total

1.  Practical and ethical complexities of MAiD: Examples from Quebec.

Authors:  Gitte Koksvik
Journal:  Wellcome Open Res       Date:  2020-11-23

2.  Conscientious objection to medical assistance in dying in rural/remote nursing.

Authors:  Julia Panchuk; Lorraine M Thirsk
Journal:  Nurs Ethics       Date:  2021-01-11       Impact factor: 2.874

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.